ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CITIGROUP INC | 138,856 | $281,878 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 349,358 | $709,197 | 0.00% |
| GOLDMAN SACHS GROUP INC | 204,639 | $415,417 | 0.00% |
| Invesco Ltd. | 56,615 | $114,929 | 0.00% |
| AMALGAMATED BANK | 15,807 | $32 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 1,820 | $3,452 | 0.00% |
| BANK OF MONTREAL /CAN/ | 320,184 | $656,377 | 0.00% |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 500 | $1,015 | 0.00% |
| ProShare Advisors LLC | 27,170 | $55,156 | 0.00% |
| Bank of New York Mellon Corp | 451,467 | $916,478 | 0.00% |
| Citadel Advisors | 96,200 | $195,286 | 0.00% |
| Citadel Advisors | 23,200 | $47,096 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 4,470 | $9 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 71,400 | $144,942 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 96,600 | $196,098 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 208,437 | $423,128 | 0.00% |
| GTS SECURITIES LLC | 11,100 | $22,533 | 0.00% |
| SIGNATUREFD, LLC | 3,810 | $7,734 | 0.00% |
| HARBOR INVESTMENT ADVISORY, LLC | 803 | $1,630 | 0.00% |
| Daiwa Securities Group Inc. | 395 | $1 | 0.00% |
External links
This page lists ARBUTUS BIOPHARMA CORP's shareholders in Q3 2023. To view ARBUTUS BIOPHARMA CORP's shareholder history, click here.